Common use of AND ANNUAL REPORTS Clause in Contracts

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and a copy of the written process required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Arc shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and a copy of the written process required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Arc;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Post Acute Medical shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board managing members who are responsible for satisfying the Board of Directors Manager’s compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow for the purpose of completing the required by Section III.A.4;‌Certification;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors Manger’s training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Oglethorpe shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Oglethorpe that includes a summary of all current and prior engagements between Oglethorpe and the IRO;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Agendia shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with with‌ respect to Healogics;‌Agendia that includes a summary of all current and prior engagements between Agendia and the IRO; 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Respironics shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌III.A.2;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations requirements described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.BIII.B.1; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, training and when the training was provided);‌ 7. the following information regarding the IRO(s): a description of (a) identity, address, and phone numberthe Focus Arrangements Tracking System required by Section III.D.1.a; (b) a copy of the engagement letterinternal review and approval process required by Section III.D.1.g; and (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; tracking and (d) a certification from the IRO regarding its professional independence monitoring procedures and objectivity with respect to Healogics;‌other Focus Arrangements Procedures required by Section III.D.1;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌III.F;‌ 9. a description of the Disclosure Program required by Section III.FIII.G; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.H;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 180 days after the Effective Date, Healogics SMMC shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with with‌ respect to Healogics;‌SMMC that includes a summary of all current and prior engagements between SMMC and the IRO; 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics ResMed shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board Compliance Oversight Committee members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. a description of (a) the Base Price List and the Discounted Price List required by Section III.D.2.a and III.D.2.b; (b) the Pricing Protocol required by Section‌‌ III.D.2.c and (c) the other Invoiced Sales Procedures required by Section III.D.2; 9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics VirtuOx shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations requirements described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌VirtuOx that includes a summary of all current and prior engagements between VirtuOx and the IRO;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Sutter shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board Committee members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Sutter that includes a summary of all current and prior engagements between Sutter and the IRO;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Vascular Access Centers shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:include:‌ 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members General Partner (or General Partner on behalf of the General Partner) who are is responsible for satisfying the Board of Directors General Partner compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process required by Section III.A.4;‌for Certifying Employees;‌ 5. a list of all the Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors General Partners training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Vascular Access Centers or that it does not have a prohibited relationship with Vascular Access Centers as set forth in Section III.E.4, as applicable;‌ 89. a description of the risk assessment and internal review process required by Section III.E;‌ 9III.F;‌ 10. a description of the Disclosure Program required by Section III.FIII.G; 1011. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.H;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics the GIS Parties shall submit a written report to OIG summarizing the status of its their implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance Officers required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance Officers may have;‌ 2. the names and positions of the members of the Compliance Committee Committees required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board Boards of Directors Directors’ compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and a copy of the written process required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B;III.B;‌‌ 6. the Training Plan required by Section III.C.1 and a description of the Board Boards of Directors Directors’ training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Flower Mound shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations requirements described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌provided);‌‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics AmeriCare shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and required by Section III.A.4 as well as a copy of the written process for Certifying Employees to follow for the purpose of completing the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a a‌ certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌AmeriCare; 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics GSMC shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations requirements described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌provided);‌‌‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Guardian shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Guardian that includes a summary of all current and prior engagements between Guardian and the IRO;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Ventura County shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board Committee members who are responsible for satisfying the Board of Directors Committee compliance obligations requirements described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors Committee training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with with‌ respect to Healogics;‌Ventura County that includes a summary of all current and prior engagements between Ventura County and the IRO; 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 150 days after the Effective Date, Healogics Signature shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and a copy written process‌ for Certifying Employees to follow for the purpose of completing the written process certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Signature;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌‌‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics MTL shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors Managers compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and required by Section III.A.4 as well as a copy of the written process required by Section III.A.4;‌for Certifying Employees;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors Managers training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌MTL;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics ACell shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance CCO required by Section III.AIII.A.1, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance CCO may have;‌ 2. the names and positions of the members of the Corporate Compliance Committee required by Section III.A;‌III.A.2;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees and a copy of the written process required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, training and when the training was provided);‌ 7. a description of the risk assessment and internal review process required by Section III.D;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ACell;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics Xxxxxxxxx shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌Northwell or that it does not have a prohibited relationship with Xxxxxxxxx as set forth in Section III.E.3, that includes a summary of all current and prior engagements or relationships between Northwell and the IRO, as applicable;‌ 89. a description of the risk assessment and internal review process required by Section III.E;‌III.F;‌ 910. a description of the Disclosure Program required by Section III.FIII.G; 1011. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.H;‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics CRMC shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the all Policies and Procedures required by Section III.B; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌ 7. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.g; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;‌ 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌and‌‌

AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 120 days after the Effective Date, Healogics BMG shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, business address, business phone number, and position description of the Chief Compliance Officer and Vice President of Regional Compliance required by Section III.A, and a summary of other noncompliance job responsibilities the Chief Compliance Officer and Vice President of Regional Compliance may have;‌ 2. the names and positions of the members of the Compliance Committee required by Section III.A;‌ 3. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;‌ 4. the names and positions of the Certifying Employees required by Section III.A.4 and a copy of the written process for Certifying Employees to follow in order to complete the certification required by Section III.A.4;‌ 5. a list of the Policies and Procedures required by Section III.B; ; 6. the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);‌provided);‌‌‌ 7. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Healogics;‌BMG that includes a summary of all current and prior engagements between BMG and the IRO;‌ 8. a description of the risk assessment and internal review process required by Section III.E;‌ 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G;‌‌III.G;‌